Customized hydroxyapatites for bone-tissue engineering and drug delivery applications: a review
Source abstract
Abstract
Hydroxyapatite (HAP, Ca10(PO4)6(OH)2) remains to be the foremost choice in biomedical field right from repair/replacement for the damaged hard tissues to be acting as effective drug delivery agent for tissue healing. Though, HAP is similar in composition with the mineral component of bone, some issues such as lack of mechanical and antimicrobial properties, low degradation, lesser drug loading capability, lower stimuli responsiveness, and targeted deficiency have continuously posed major challenges. However, enactment of various physicochemical, biological, mechanical properties can be improved by articulating particles morphology, size, structure, porosity, synthesis technique, and ionic substitution into HAP structure. Unique structure of HAP permits various anionic and cationic substitutions. Among the available synthesis routes, hydrothermal and microwave-assisted techniques seem to be the most suitable techniques to synthesize HAP with close control over desirable properties. This review primarily focuses on highlighting the customization of desirable properties by controlling particles size, morphology, synthesis parameters, and substitution of mono/multi ions into HAP structure to obtain a product appropriate for bone-tissue engineering and drug delivery applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Chemical Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Suchanek W, Yoshimura M (1998) Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 13:94–11710.1557/JMR.1998.0015 ↗
2. Ratnayake JTB, Mucalo M, Dias GJ (2017) Substituted hydroxyapatites for bone regeneration: a review of current trends. J Biomed Mater Res—Part B Appl Biomater 105:1285–129910.1002/jbm.b.33651 ↗
3. Okazaki Y, Gotoh E (2005) Comparison of metal release from various metallic biomaterials in vitro. Biomaterials 26:11–2110.1016/j.biomaterials.2004.02.005 ↗
4. Shastri V (2005) Non-degradable biocompatible polymers in medicine: past, present and future. Curr Pharm Biotechnol 4:331–33710.2174/1389201033489694 ↗
5. Lyu S, Untereker D (2009) Degradability of polymers for implantable biomedical devices. Int J Mol Sci 10:4033–406510.3390/ijms10094033 ↗
6. Cui FZ, Li Y, Ge J (2007) Self-assembly of mineralized collagen composites. Mater Sci Eng R: Rep. 57:1–2710.1016/j.mser.2007.04.001 ↗
7. Murugan R, Ramakrishna S (2005) Development of nanocomposites for bone grafting. Compos Sci Technol 65:2385–240610.1016/j.compscitech.2005.07.022 ↗
8. Kalita SJ, Bhardwaj A, Bhatt HA (2007) Nanocrystalline calcium phosphate ceramics in biomedical engineering. Mater Sci Eng C 27:441–44910.1016/j.msec.2006.05.018 ↗
9. Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74:1487–151010.1111/j.1151-2916.1991.tb07132.x ↗
10. Arcos D, Vallet-Regi M (2013) Bioceramics for drug delivery. Acta Mater 61:890–91110.1016/j.actamat.2012.10.039 ↗
11. Mayer C, Bagheri F, Zandi M, Urch H, Mirzadeh H, Eslaminejad MB, Mivehchi H (2009) Biocompatibility evaluation of nano-rod hydroxyapatite/gelatin coated with nano-HAp as a novel scaffold using mesenchymal stem cells. J Biomed Mater Res Part A 92A:1244–1255
12. Ghanaati S, Barbeck M, Detsch R, Deisinger U, Hilbig U, Rausch V, Sader R, Unger RE, Ziegler G, Kirkpatrick CJ (2012) The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: Histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate cer. Biomed Mater 7:1–1410.1088/1748-6041/7/1/015005 ↗
13. Elliott JC (1994) Hydroxyapatite and nonstoichiometric apatites. In: Studies in inorganic chemistry. 111–189
14. Leventouri T (2006) Synthetic and biological hydroxyapatites: crystal structure questions. Biomaterials 27:3339–334210.1016/j.biomaterials.2006.02.021 ↗
15. Posner AS, Perloff A, Diorio AF (1958) Refinement of the hydroxyapatite structure. Acta Crystallogr 11:308–30910.1107/S0365110X58000815 ↗
16. Boanini E, Gazzano M, Bigi A (2010) Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomater 6:1882–189410.1016/j.actbio.2009.12.041 ↗
17. Wang L, Nancollas GH (2008) Calcium orthophosphates: crystallization and dissolution. Chem Rev 108:4628–466910.1021/cr0782574 ↗
18. Vallet-Regí M, González-Calbet JM (2004) Calcium phosphates as substitution of bone-tissues. Prog Solid State Chem 32:1–3110.1016/j.progsolidstchem.2004.07.001 ↗
19. Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29:2941–295310.1016/j.biomaterials.2008.04.023 ↗
20. Yoshimura M, Suda H, Okamoto K, Ioku K (1994) Hydrothermal synthesis of biocompatible whiskers. J Mater Sci 29:3399–340210.1007/BF00352039 ↗
21. Zhao Y, Zhang Y, Ning F, Guo D, Xu Z (2007) Synthesis and cellular biocompatibility of two kinds of HAP with different nanocrystal morphology. J Biomed Mater Res Part B, Appl Biomater 83:340–344
22. Vallet-Regí M (2001) Ceramics for medical applications. Dalton Trans 2:97–10810.1039/b007852m ↗
23. Albrektsson T, Johansson C (2001) Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10:S96–S10110.1007/s005860100282 ↗
24. D’ Elia NL, Mathieu C, Hoemann CD, Laiuppa JA, Santillan GE, Messina PV (2015) Bone-repair properties of biodegradable hydroxyapatite nano-rods superstructures. Nanoscale 7:18751–1876210.1039/C5NR04850H ↗
25. Gautam CR, Kumar S, Biradar S, Jose S, Mishra VK (2016) Synthesis and enhanced mechanical properties of MgO substituted hydroxyapatite: a bone substitute material. RSC Adv 6:67565–6757410.1039/C6RA10839C ↗
26. Bandyopadhyay A, Bernard S, Xue W, Böse S (2006) Calcium phosphate-based resorbable ceramics: Influence of MgO, ZnO, and SiO2 dopants. J Am Ceram Soc 89:2675–268810.1111/j.1551-2916.2006.01207.x ↗
27. Curran DJ, Fleming TJ, Towler MR, Hampshire S (2011) Mechanical parameters of strontium doped hydroxyapatite sintered using microwave and conventional methods. J Mech Behav Biomed Mater 4:2063–207310.1016/j.jmbbm.2011.07.005 ↗
28. Bose S, Banerjee A, Dasgupta S, Bandyopadhyay A (2009) Synthesis, processing, mechanical, and biological property characterization of hydroxyapatite whisker-reinforced hydroxyapatite composites. J Am Ceram Soc 92:323–33010.1111/j.1551-2916.2008.02881.x ↗
29. Li H, Song X, Li B, Kang J, Liang C, Wang H, Yu Z, Qiao Z (2017) Carbon nanotube-reinforced mesoporous hydroxyapatite composites with excellent mechanical and biological properties for bone replacement material application. Mater Sci Eng C 77:1078–108710.1016/j.msec.2017.04.048 ↗
30. Dasgupta S, Tarafder S, Bandyopadhyay A, Bose S (2013) Effect of grain size on mechanical, surface and biological properties of microwave sintered hydroxyapatite. Mater Sci Eng C 33:2846–285410.1016/j.msec.2013.03.004 ↗
31. Wang J, Shaw LL (2009) Nanocrystalline hydroxyapatite with simultaneous enhancements in hardness and toughness. Biomaterials 30:6565–657210.1016/j.biomaterials.2009.08.048 ↗
32. Ravi ND, Balu R, Sampath Kumar TS (2012) Strontium-substituted calcium deficient hydroxyapatite nanoparticles: Synthesis, characterization, and antibacterial properties. J Am Ceram Soc 95:2700–270810.1111/j.1551-2916.2012.05262.x ↗
33. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GC, Cui FZ (1998) Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J Mater Sci Mater Med 9:129–13410.1023/A:1008811501734 ↗
34. Kumar GS, Govindan R, Girija EK (2014) In situ synthesis, characterization and in vitro studies of ciprofloxacin loaded hydroxyapatite nanoparticles for the treatment of osteomyelitis. J Mater Chem B 2:5052–506010.1039/C4TB00339J ↗
35. Dorozhkin SV (2013) Calcium orthophosphate-based bioceramics. Materials 6:3840–394210.3390/ma6093840 ↗
36. Lin K, Chang J (2015) Structure and properties of hydroxyapatite for biomedical applications. In: Hydroxyapatite (HAp) for biomedical applications, Elsevier Ltd. 3–1910.1016/B978-1-78242-033-0.00001-8 ↗
37. Zhou H, Lee J (2011) Nanoscale hydroxyapatite particles for bone-tissue engineering. Acta Biomater 7:2769–278110.1016/j.actbio.2011.03.019 ↗
38. Ferraz MP, Monteiro FJ, Manuel CM (2004) Hydroxyapatite nanoparticles: a review of preparation methodologies. J Appl Biomater Biomech 2:74–80
39. Yang LX, Yin JJ, Wang LL, Xing GX, Yin P, Liu QW (2012) Hydrothermal synthesis of hierarchical hydroxyapatite: preparation, growth mechanism and drug release property. Ceram Int 38:495–50210.1016/j.ceramint.2011.07.033 ↗
40. Sereni A, Trombelli L, Mischiati C, del Senno L, Sibilla P, Banzi M, Manzati E, Aguiari G (2009) Effects of a hydroxyapatite-based biomaterial on gene expression in osteoblast-like cells. J Dent Res 85:354–358
41. Yuan X, Zhu B, Ma X, Tong G, Su Y, Zhu X (2013) Low temperature and template-free synthesis of hollow hydroxy zinc phosphate nanospheres and their application in drug delivery. Langmuir 29:12275–1228310.1021/la402743b ↗
42. Liu TY, Chen SY, Liu DM, Liou SC (2005) On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery. J Controlled Release 107:112–12110.1016/j.jconrel.2005.05.025 ↗
43. Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi CL, Walsh D, Mann S, Roveri N (2007) Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater 17:2180–218810.1002/adfm.200600361 ↗
44. Park J, Lakes RS (2007) Biomaterials: an introduction. 3rd edn. Springer, USA
45. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R (2000) Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21:1803–181010.1016/S0142-9612(00)00075-2 ↗
46. Huang J, Best SM, Bonfield W, Brooks RA, Rushton N, Jayasinghe SN, Edirisinghe MJ (2004) In vitro assessment of the biological response to nano-sized hydroxyapatite. J Mater Sci: Mater Med 15:441–445
47. Shi Z, Huang X, Cai Y, Tang R, Yang D (2009) Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater 5:338–34510.1016/j.actbio.2008.07.023 ↗
48. Lemons JE, Catledge SA, Lacefield WR, Woodard S, Fries MD, Vohra YK, Venugopalanc R (2002) Nanostructured ceramics for biomedical implants. J Nanosci Nanotechnol 2:293–31210.1166/jnn.2002.116 ↗
49. Webster TJ, Siegel RW, Bizios R (2001) Enhanced surface and mechanical properties of nanophase ceramics to achieve orthopaedic/dental implant efficacy. Key Eng Mater 192–195:321–324
50. Okada M, Furukawa K, Serizawa T, Yanagisawa Y, Tanaka H, Kawai T, Furuzono T (2009) Interfacial interactions between calcined hydroxyapatite nanocrystals and substrates. Langmuir 25:6300–630610.1021/la804274q ↗
51. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R (2000) Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 51:475–48310.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.0.CO;2-9 ↗
52. Hahn H (2003) Unique features and properties of nanostructured materials. Adv Eng Mater 5:277–28410.1002/adem.200310091 ↗
53. Ramesh S, Tan CY, Bhaduri SB, Teng WD, Sopyan I (2008) Densification behaviour of nanocrystalline hydroxyapatite bioceramics. J Mater Process Technol 206:221–23010.1016/j.jmatprotec.2007.12.027 ↗
54. Padilla S, Izquierdo-Barba I, Vallet-Regí M (2008) High specific surface area in nanometric carbonated hydroxyapatite. Chem Mater 20:5942–594410.1021/cm801626k ↗
55. Zhao XY, Zhu YJ, Chen F, Lu BQ, Wu J (2013) Nanosheet-assembled hierarchical nanostructures of hydroxyapatite: surfactant-free microwave-hydrothermal rapid synthesis, protein/DNA adsorption and pH-controlled release. CrystEngComm 15:206–21210.1039/C2CE26315G ↗
56. Yang L, Sheldon BW, Webster TJ (2010) Nanophase ceramics for improved drug delivery: current opportunities and challenges. Am Ceram Soc Bull 89:24–32
57. Padmanabhan SK, Balakrishnan A, Chu MC, Lee YJ, Kim TN, Cho SJ (2009) Sol-gel synthesis and characterization of hydroxyapatite nanorods. Particuology 7:466–47010.1016/j.partic.2009.06.008 ↗
58. Lin K, Chang J, Lu J, Wu W, Zeng Y (2007) Properties of β-Ca3(PO4)2 bioceramics prepared using nano-size powders. Ceram Int 33:979–98510.1016/j.ceramint.2006.02.011 ↗
59. Guo YP, Yao YB, Ning CQ, Guo YJ, Chu LF (2011) Fabrication of mesoporous carbonated hydroxyapatite microspheres by hydrothermal method. Mater Lett 65:2205–220810.1016/j.matlet.2011.04.057 ↗
60. Agrawal S, Kelkar M, De A, Kulkarni AR, Gandhi MN (2016) Surfactant free novel one-minute microwave synthesis, characterization and cell toxicity study of mesoporous strontium hydroxyapatite nanorods. RSC Adv 6:94921–9492610.1039/C6RA21708G ↗
61. Kawachi G, Sasaki S, Nakahara K, Ishida EH, Ioku K (2009) Porous apatite carrier prepared by hydrothermal method. Key Eng Mater 309–311:935–938
62. Zhang C, Li C, Huang S, Hou Z, Cheng Z, Yang P, Peng C, Lin J (2010) Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 31:3374–338310.1016/j.biomaterials.2010.01.044 ↗
63. Grandjean-Laquerriere A, Laquerriere P, Laurent-Maquin D, Guenounou M, Phillips TM (2004) The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro. Biomaterials 25:5921–592710.1016/j.biomaterials.2004.02.003 ↗
64. Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S (2013) Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci 110:10753–1075810.1073/pnas.1308345110 ↗
65. Zhao P, Liu M-C, Lin H-C, Sun X-Y, Li Y-Y, Yan S-Q (2017) Synthesis and drug delivery applications for mesoporous silica nanoparticles. J Med Biotechnol 1:1–5
66. Shao F, Liu L, Fan K (2012) Ibuprofen loaded porous calcium phosphate nanospheres for skeletal drug delivery system. J Mater Sci 47:1054–105810.1007/s10853-011-5894-9 ↗
67. Murugan R, Ramakrishna S (2006) Designing biological apatite suitable for neomycin delivery. J Mater Sci 41:4343–434710.1007/s10853-006-6157-z ↗
68. Le Huec JC, Schaeverbeke T, Clement D, Faber J, Le Rebeller A (1995) Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials 16:113–11810.1016/0142-9612(95)98272-G ↗
69. Capuccini C, Torricelli P, Boanini E, Gazzano M, Giardino R, Bigi A (2009) Interaction of Sr-doped hydroxy apatite nanocrystals with osteoclast and osteoblast-like cells. J Biomed Mater Res—Part A 89:594–60010.1002/jbm.a.31975 ↗
70. Bracci B, Torricelli P, Panzavolta S, Boanini E, Giardino R, Bigi A (2009) Effect of Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of calcium phosphate biomimetic coatings. J Inorg Biochem 103:1666–167410.1016/j.jinorgbio.2009.09.009 ↗
71. Legeros RZ (1993) Biodegradation and bioresorption phosphate ceramics of calcium. Clin Mater 14:65–8810.1016/0267-6605(93)90049-D ↗
72. Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscino G (2007) Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater 3:961–96910.1016/j.actbio.2007.05.006 ↗
73. Norhidayu D, Sopyan I, Ramesh S (2008) Development of zinc doped hydroxyapatite for bone implant applications. In: Proceedings of the International Conference on Construction and Building Technology 2008:257–270
74. Bianco A, Cacciotti I, Lombardi M, Montanaro L (2009) Si-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sinterability. Mater Res Bull 44:345–35410.1016/j.materresbull.2008.05.013 ↗
75. Landi E, Tampieri A, Mattioli-Belmonte M, Celotti G, Sandri M, Gigante A, Fava P, Biagini G (2006) Biomimetic Mg- and Mg2CO3-substituted hydroxyapatites: synthesis characterization and in vitro behaviour. J Eur Ceram Soc 26:2593–260110.1016/j.jeurceramsoc.2005.06.040 ↗
76. Kumta PN, Sfeir C, Lee DH, Olton D, Choi D (2005) Nanostructured calcium phosphates for biomedical applications: Novel synthesis and characterization. Acta Biomater 1:65–8310.1016/j.actbio.2004.09.008 ↗
77. Yasukawa A, Ouchi S, Kandori K, Ishikawa T (1996) Preparation and characterization of magnesium-calcium hydroxyapatites. J Muter Chem 6:1401–140510.1039/JM9960601401 ↗
78. Bigi A, Falini G, Foresti E, Gazzano M, Ripamonti A, Roveri N (1996) Rietveld structure refinements of calcium hydroxylapatite containing magnesium. Acta Crystallogr Sect B: Struct Sci 52:87–9210.1107/S0108768195008615 ↗
79. Gibson IR, Bonfield W (2002) Preparation and characterization of magnesium/carbonate co-substituted hydroxyapatites. J Mater Sci: Mater Med 13:685–693
80. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S (2008) Biomimetic Mg-substituted hydroxyapatite: From synthesis to in vivo behaviour. J Mater Sci: Mater Med 19:239–247
81. Bertinetti L, Drouet C, Combes C, Rey C, Tampieri A, Coluccia S, Martra G (2009) Surface characteristics of nanocrystalline apatites: effect of Mg surface enrichment on morphology, surface hydration species, and cationic environments. Langmuir 25:5647–565410.1021/la804230j ↗
82. Zyman Z, Tkachenko M, Epple M, Polyakov M, Naboka M (2006) Magnesium-substituted hydroxyapatite ceramics. Mater Werkst 37:474–47710.1002/mawe.200600022 ↗
83. Fadeev IV, Shvorneva LI, Barinov SM, Orlovskii VP (2003) Synthesis and structure of magnesium-substituted hydroxyapatite. Inorg Mater 39:947–95010.1023/A:1025509305805 ↗
84. Bigi A, Boanini E, Capuccini C, Gazzano M (2007) Strontium-substituted hydroxyapatite nanocrystals. Inorg Chim Acta 360:1009–101610.1016/j.ica.2006.07.074 ↗
85. Verberckmoes SC, Behets GJ, Oste L, Bervoets AR, Lamberts LV, Drakopoulos M, Somogyi A, Cool P, Dorriné W, De Broe ME et al. (2004) Effects of strontium on the physicochemical characteristics of hydroxyapatite. Calcif Tissue Int 75:405–41510.1007/s00223-004-0260-4 ↗
86. Shen Y, Liu J, Lin K, Zhang W (2012) Synthesis of strontium substituted hydroxyapatite whiskers used as bioactive and mechanical reinforcement material. Mater Lett 70:76–7910.1016/j.matlet.2011.11.093 ↗
87. Kim HW, Koh YH, Kong YM, Kang JG, Kim HE (2004) Strontium substituted calcium phosphate biphasic ceramics obtained by a powder precipitation method. J Mater Sci: Mater Med 15:1129–1134
88. Kavitha M, Subramanian R, Narayanan R, Udhayabanu V (2014) Solution combustion synthesis and characterization of strontium substituted hydroxyapatite nanocrystals. Powder Technol 253:129–13710.1016/j.powtec.2013.10.045 ↗
89. Ovesen J, Moller-Madsen B, Thomsen JS, Danscher G, Mosekilde L (2001) The positive effects of zinc on skeletal strength in growing rats. Bone 29:565–57010.1016/S8756-3282(01)00616-0 ↗
90. Hall SL, Dimai HP, Farley JR (1999) Effects of zinc on human skeletal alkaline phosphatase activity in vitro. Calcif Tissue Int 64:163–17210.1007/s002239900597 ↗
91. Yamaguchi M (1998) Role of Zinc in Bone Formation and Bone Resorption. J Trace Elem Exp Med 11:119–13510.1002/(SICI)1520-670X(1998)11:2/3<119::AID-JTRA5>3.0.CO;2-3 ↗
92. Miao S, Cheng K, Weng W, Du P, Shen G, Han G, Yan W, Zhang S (2008) Fabrication and evaluation of Zn containing fluoridated hydroxyapatite layer with Zn release ability. Acta Biomater 4:441–44610.1016/j.actbio.2007.08.013 ↗
93. Ren F, Xin R, Ge X, Leng Y (2009) Characterization and structural analysis of zinc-substituted hydroxyapatites. Acta Biomater 5:3141–314910.1016/j.actbio.2009.04.014 ↗
94. Bigi A, Foresti E, Gandolfi M, Gazzano M, Roveri N (1997) Isomorphous substitutions in β-tricalcium phosphate: The different effects of zinc and strontium. J Inorg Biochem 66:259–26510.1016/S0162-0134(96)00219-X ↗
95. Kaygili O, Tatar C (2012) The investigation of some physical properties and microstructure of Zn-doped hydroxyapatite bioceramics prepared by sol-gel method. J Sol–Gel Sci Technol 61:296–30910.1007/s10971-011-2627-0 ↗
96. Jallot E, Nedelec JM, Grimault AS, Chassot E, Grandjean-Laquerriere A, Laquerriere P, Laurent-Maquin D (2005) STEM and EDXS characterisation of physico-chemical reactions at the periphery of sol-gel derived Zn-substituted hydroxyapatites during interactions with biological fluids. Colloids Surf B: Biointerfaces 42:205–21010.1016/j.colsurfb.2005.03.001 ↗
97. Yingguang L, Zhuoru Y, Jiang C (2007) Preparation, characterization and antibacterial property of cerium substituted hydroxyapatite nanoparticles. J Rare Earths 25:452–45610.1016/S1002-0721(07)60455-4 ↗
98. Feng Z, Liao Y, Ye M (2005) Synthesis and structure of cerium-substituted hydroxyapatite. J Mater Sci: Mater Med 16:417–421
99. Reardon PJT, Huang J, Tang J (2013) Morphology controlled porous calcium phosphate nanoplates and nanorods with enhanced protein loading and release functionality. Adv Healthc Mater 2:682–68610.1002/adhm.201200276 ↗
100. Medvecký Ľ, Štulajterová R, Parilák Ľ, Trpčevská J, Ďurišin J, Barinov SM (2006) Influence of manganese on stability and particle growth of hydroxyapatite in simulated body fluid. Colloids Surf A: Physicochem Eng Asp 281:221–22910.1016/j.colsurfa.2006.02.042 ↗